The ETF's investment objectives are to provide holders, through an actively managed portfolio, with (i) regular cash distributions, (ii) the opportunity for capital appreciation by investing on an equal weight basis in a portfolio of securities of the 20 health care companies (as determined by the Manager in its discretion) with the largest market capitalization listed on a North American stock exchange, and (iii) lower overall volatility of returns on the portfolio than would be experienced by owning a portfolio of securities of such issuers directly, by employing a covered call option writing program. The foreign currency exposure attributable to the Units will not be hedged back to the Canadian dollar.
Investor suitability
For those who:
| 1m | 3m | 6m | YTD | 1y | 2y | SI | |
|---|---|---|---|---|---|---|---|
| FHI.B | 1.04% | 3.08% | 11.16% | 3.78% | 13.73% | 6.43% | 10.54% |
| Benchmark | 0.31% | 3.83% | 12.85% | 8.17% | 21.18% | 9.40% | 35.37% |
| As at: 30 Sep 2020 - Benchmark: S&P 500 Health Care Index (Unhedged) | |||||||
As at September 30, 2020
The indicated rates of return are the historical annual compounded total returns, including changes in unit value and do not take into account sales, redemption or optional charges or income taxes payable by a security holder that would have reduced returns.
S&P 500 Health Care Index is a market capitalization weighted index. The constituents of the Index are a subset of the constituents of the S&P 500 Index that have been classified as part of the health care sector according to the Global Industry Classification Standard.
Fund Characteristics | |
| Gross Option Premium* | 6.55% |
|---|---|
| Current Dividend Yield1 | 2.03% |
| Price/Earnings Ratio | 21.46 |
| Price/Book Ratio | 3.64 |
| As at 30 Sep, 2020 * Gross Option Premiums represent those received on 18 Sep, 2020 1 The Current Dividend Yield represents the gross yield on the ETF`s underlying portfolio of securities. It is not the yield or the distribution investors will receive by virtue of an investment in the ETF. | |
Fund Statistics | |
| P/S Ratio (TTM) (Long) | 1.58 |
|---|---|
| P/C Ratio (TTM) (Long) | 12.49 |
| ROA % (TTM) (Long) | 6.86 |
| ROE % (TTM) (Long) | 25.79 |
| As at 30 Sep, 2020 | |
Number of securities: 40
| Security Type | % |
|---|---|
| Foreign Stock | 100.00% |
| Name | Security Type | ISIN | Ticker | % |
|---|---|---|---|---|
| ANTHEM INC | Foreign Stock | US0367521038 | ANTM US | 5.75 |
| DANAHER CORP | Foreign Stock | US2358511028 | DHR US | 5.48 |
| THERMO FISHER SCIENTIFIC INC | Foreign Stock | US8835561023 | TMO US | 5.44 |
| HUMANA INC | Foreign Stock | US4448591028 | HUM US | 5.39 |
| CIGNA CORP | Foreign Stock | US1255231003 | CI US | 5.34 |
| UNITEDHEALTH GROUP INC | Foreign Stock | US91324P1021 | UNH US | 5.23 |
| STRYKER CORP | Foreign Stock | US8636671013 | SYK US | 5.19 |
| PFIZER INC | Foreign Stock | US7170811035 | PFE US | 5.03 |
| BECTON DICKINSON AND CO | Foreign Stock | US0758871091 | BDX US | 5.03 |
| MEDTRONIC PLC | Foreign Stock | IE00BTN1Y115 | MDT US | 5.02 |
| CVS HEALTH CORP | Foreign Stock | US1266501006 | CVS US | 4.98 |
| ZOETIS INC | Foreign Stock | US98978V1035 | ZTS US | 4.97 |
| BRISTOL-MYERS SQUIBB CO | Foreign Stock | US1101221083 | BMY US | 4.93 |
| ABBOTT LABORATORIES | Foreign Stock | US0028241000 | ABT US | 4.90 |
| JOHNSON & JOHNSON | Foreign Stock | US4781601046 | JNJ US | 4.74 |
| ABBVIE INC | Foreign Stock | US00287Y1091 | ABBV US | 4.57 |
| GILEAD SCIENCES INC | Foreign Stock | US3755581036 | GILD US | 4.56 |
| MERCK & CO INC | Foreign Stock | US58933Y1055 | MRK US | 4.53 |
| ELI LILLY AND CO | Foreign Stock | US5324571083 | LLY US | 4.50 |
| AMGEN INC | Foreign Stock | US0311621009 | AMGN US | 4.48 |
| ABT US CALL 115 11/20/20 ABBOTT LABORATORIES (21/11/2020) | Option | 0.00 | ||
| AMGN US CALL 240 11/20/20 AMGEN INC (21/11/2020) | Option | 0.00 | ||
| JNJ US CALL 150 11/20/20 JOHNSON & JOHNSON (21/11/2020) | Option | 0.00 | ||
| LLY US CALL 150 11/20/20 ELI LILLY & CO (21/11/2020) | Option | 0.00 | ||
| BMY US CALL 62.5 11/20/20 BRISTOL-MYERS SQUIBB CO (21/11/2020) | Option | 0.00 | ||
| ABBV US CALL 87.5 11/20/20 ABBVIE INC (21/11/2020) | Option | 0.00 | ||
| MDT US CALL 115 11/20/20 MEDTRONIC PLC (21/11/2020) | Option | 0.00 | ||
| UNH US CALL 340 11/20/20 UNITEDHEALTH GROUP INC (21/11/2020) | Option | 0.00 | ||
| SYK US CALL 230 11/20/20 STRYKER CORP (21/11/2020) | Option | 0.00 | ||
| GILD US CALL 62.5 11/20/20 GILEAD SCIENCES INC COM (21/11/2020) | Option | 0.00 | ||
| MRK US CALL 80 11/20/20 MERCK & CO INC (21/11/2020) | Option | 0.00 | ||
| ZTS US CALL 165 11/20/20 ZOETIS INC (21/11/2020) | Option | 0.00 | ||
| PFE US CALL 39 11/20/20 PFIZER INC (21/11/2020) | Option | 0.00 | ||
| TMO US CALL 480 11/20/20 THERMO FISHER SCIENTIFIC (21/11/2020) | Option | 0.00 | ||
| CVS US CALL 60 11/20/20 CVS CAREMARK CORP (21/11/2020) | Option | 0.00 | ||
| BDX US CALL 240 11/20/20 BECTON DICKINSON AND CO (21/11/2020) | Option | 0.00 | ||
| DHR US CALL 230 11/20/20 DANAHER CORP (21/11/2020) | Option | 0.00 | ||
| HUM US CALL 440 11/20/20 HUMANA INC (21/11/2020) | Option | 0.00 | ||
| CI US CALL 180 11/20/20 CIGNA CORPORATION COM (21/11/2020) | Option | 0.00 | ||
| ANTM US CALL 300 11/20/20 ANTHEM INC CLL (21/11/2020) | Option | 0.00 | ||
| Currency Security | 0.00 | |||
As at: 23 October 2020 | 100.06% | |||
Twelve month trailing distribution yield : 7.94% (as at 23 Oct 2020)
| FHI.B | Total | Cash | Reinvested | Eligible dividends | Non eligible dividends | Other income | Capital Gains | Return of capital | Foreign Income | Foreign tax paid |
|---|---|---|---|---|---|---|---|---|---|---|
| SI | $1.57840 | $1.57840 | - | - | - | - | $0.20669 | $0.48426 | $0.17135 | $0.02570 |
| 2020 + | $0.74180 | $0.74180 | - | - | - | - | - | - | - | - |
| 24-Sep | $0.28130 | $0.28130 | - | - | - | - | - | - | - | - |
| 24-Jun | $0.29900 | $0.29900 | - | - | - | - | - | - | - | - |
| 25-Mar | $0.16150 | $0.16150 | - | - | - | - | - | - | - | - |
| 2019 + | $0.60530 | $0.60530 | - | - | - | - | - | $0.45965 | $0.17135 | $0.02570 |
| 23-Dec | $0.12960 | $0.12960 | - | - | - | - | - | $0.09842 | $0.03669 | $0.00550 |
| 24-Sep | $0.15350 | $0.15350 | - | - | - | - | - | $0.11656 | $0.04345 | $0.00652 |
| 24-Jun | $0.15350 | $0.15350 | - | - | - | - | - | $0.11656 | $0.04345 | $0.00652 |
| 25-Mar | $0.16870 | $0.16870 | - | - | - | - | - | $0.12811 | $0.04776 | $0.00716 |
| 2018 + | $0.23130 | $0.23130 | - | - | - | - | $0.20669 | $0.02461 | - | - |
| 21-Dec | $0.11570 | $0.11570 | - | - | - | - | $0.10339 | $0.01231 | - | - |
| 24-Sep | $0.11560 | $0.11560 | - | - | - | - | $0.10330 | $0.01230 | - | - |
(1) Future distribution dates may be amended at any time. (2) Reinvested distributions are not paid in cash but instead remain invested in the Fund. To recognize that these distributions have been allocated to investors for tax purposes the amounts of these distributions should be added to the adjusted cost base of the units held. (3) The characterization of distributions for tax purposes (such as dividends/other income/capital gains etc.) will not be known for certain until after the Fund's tax year end. Therefore investors will be informed of the characterization of the amounts distributed for tax purposes only for the entire year and not with each distribution. For tax purposes these amounts will be reported by brokers on official tax statements.
30 Jun, 2020 - Semi-Annual Financial Statements
31 Dec, 2019 - Annual Financial Statements
30 Jun, 2020 - Management Report of Fund Performance
31 Dec, 2019 - Annual Management Report of Fund Performance
31 Mar, 2020 - Summary of Investment Portfolio
30 Sep, 2019 - Summary of Investment Portfolio
National Instrument 81-106 Investment Fund Continuous Disclosure requires disclosure of the proxy voting record on an annual basis for the period ending on June 30 of each year. The proxy voting record must be posted on the website no later than August 31 of each year.
Canadian securities law provides that the manager of an investment funds (in this case, CI Investments Inc. ("CI")), acting on behalf of the investment fund, has the right and obligation to vote proxies relating to the investment fund's portfolio securities. As a practical matter, CI delegates this function to the applicable portfolio manager or sub-adviser, as part of the portfolio manager's or sub-adviser's general management of the investment fund assets, subject to oversight by CI. CI generally requires that applicable portfolio managers or sub-advisers vote all proxies in the best interest of CI's funds and their securityholders, as determined solely by the portfolio manager or sub-adviser, and subject to CI's proxy voting policy, the guidelines applicable to the individual portfolio manager or sub-adviser, and applicable legislation. Portfolio managers and sub-advisers are generally expected to vote on any matter for which the investment fund receives proxy materials for a meeting of securityholders of an issuer.
Proxy voting record for the most recent year:
30 Jun, 2020 - Proxy Voting Record
Warning: Documents posted on this website (including, without limitation, prospectuses) are current only as of the date on them
To access the SEDAR filings of CI First Asset Health Care Giants Covered Call ETF (Unhedged) please click here